Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial have?
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial has 60 citations in the OpenAlex counts ScholarIQ stores.
When was Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial published?
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial has 2018 year in the ScholarIQ index.
What is the open-access status of Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial?
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial has green oa status in the ScholarIQ index.
What is the DOI of Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial?
The DOI for Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial is on the source record.
What is the PMID of Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial?
The PMID for Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial is on the source record.
What is the OpenAlex record for Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial?
The OpenAlex for Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial is on the source record.